tiprankstipranks
Nuformix Plc (GB:NFX)
LSE:NFX

Nuformix Plc (NFX) Share Price & Analysis

0 Followers

NFX Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range0.18p - 0.44p
Previous Close0.21p
Volume427.23K
Average Volume (3M)2.59M
Market Cap
£1.68M
Enterprise Value1.48M
Total Cash (Recent Filing)£202.55K
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)-2.8
Beta0.77
Jul 25, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding744,309,368
10 Day Avg. Volume2,163,503
30 Day Avg. Volume2,592,817
Standard Deviation0.43
R-Squared0.00845
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

5.65%0.00%0.00%94.35%
5.65%
Insiders
0.00% Other Institutional Investors
94.35% Public Companies and
Individual Investors

NFX FAQ

What was Nuformix Plc’s price range in the past 12 months?
Nuformix Plc lowest share price was 0.18p and its highest was 0.44p in the past 12 months.
    What is Nuformix Plc’s market cap?
    Currently, no data Available
    When is Nuformix Plc’s upcoming earnings report date?
    Nuformix Plc’s upcoming earnings report date is Jul 25, 2024 which is in 92 days.
      How were Nuformix Plc’s earnings last quarter?
      Nuformix Plc released its earnings results on Dec 19, 2023. The company reported 0p earnings per share for the quarter, the consensus estimate of N/A by 0p.
        Is Nuformix Plc overvalued?
        According to Wall Street analysts Nuformix Plc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Nuformix Plc pay dividends?
          Nuformix Plc does not currently pay dividends.
          What is Nuformix Plc’s EPS estimate?
          Nuformix Plc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Nuformix Plc have?
          Nuformix Plc has 819,309,400 shares outstanding.
            What happened to Nuformix Plc’s price movement after its last earnings report?
            Nuformix Plc reported an EPS of 0p in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -12.5%.
              Which hedge fund is a major shareholder of Nuformix Plc?
              Currently, no hedge funds are holding shares in GB:NFX
              ---

              Nuformix Plc Stock Smart Score

              Company Description

              Nuformix Plc

              Nuformix PLC is a pharmaceutical development company. It is focused on building value for shareholders through its activities in drug development and by out-licensing. The company uses cocrystal technology to re-engineer the crystalline form of known small molecule drugs. Its pipeline products include NXP001, NXP002, and NXP004.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Futura Medical
              Genedrive
              N4 Pharma
              Synairgen
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis